HT Welcomes the Scientific Community with the New External Seminar Series
We are pleased to announce the launch of the Human Technopole External Seminar Series, an initiative dedicated to bringing leading researchers from around the world on campus. These scientists, working in various life sciences disciplines, will share their latest research and insights with the HT and external scientific community.
Starting from 12 September with James Briscoe, with two dates in 2024, and continuing throughout 2025, Human Technopole will host talks by internationally renowned scientists who are making significant contributions in various fields, including genomics, neurogenomics, structural biology, computational biology, health data science, biophysical modelling, and molecular cell biology.
These seminars, free and open in presence to everyone, aim to create a space for intellectual exchange that bridges different areas of expertise, contributing to the broader scientific discourse and driving innovation in the study of human health and disease.
Each seminar will take place from 16.00 to 17.00 CET at the Human Technopole Auditorium in Milan. To participate, registration is required via the forms that will be made available.
Calendar:
- 12 September 2024 – James Briscoe, The Francis Crick Institute
- 7 November 2024 – Julia Mahamid, EMBL Heidelberg
- 3 April 2025 – Kai Simons, Max Planck Institute of Molecular Cell Biology and Genetics
- 15 May 2025 – Julie Theriot, University of Washington
- 5 June 2025 – Soumya Raychaudhuri, Harvard Medical School
- 12 June 2025 – Elena Conti, Max Planck Institute of Biochemistry
- 2 October 2025 – Francesca Peri, University of Zurich
- 6 November 2025 – Erin Schuman, Max Planck Institute for Brain Research
- 13 November 2025 – Yifan Cheng, University of California, San Francisco
MORE INFO & REGISTRATION
Share:
You could also like:
-
Cancer, insomnia, ancient DNA: over 100 projects from Italian scientists at HT
Human Technopole has presented 102 research projects that were the first to benefit from the cutting-edge equipment of the National Facilities — the advanced technologies that the Institute makes available to external researchers from across Italy. The majority of studies focus on cancer and neurodegenerative diseases, accounting for 50% of the selected projects. The announcement was made this morning in Milan during “Open HT – The Open Day on Life Sciences”, an event designed to showcase Human Technopole’s achievements and outline future goals.
-
PhD Opportunity in Data Science for Medicine
Human Technopole is looking for a curious, driven, and collaborative PhD candidate to join the Research group lead by Fernanda Pinheiro as part of the EU-funded ENDAMR (Exploring Novel Drivers of Antimicrobial Resistance), a Marie Skłodowska Curie Actions (MSCA) Doctoral Network. This PhD project will develop mechanistic models grounded on microbial physiology to understand how interactions among mutually dependent bacteria influence antibiotic tolerance, community-level perturbations and evolutionary trajectories toward antimicrobial resistance.
-
Shedding light on the molecular mechanisms of Gabriele-de Vries Syndrome
Using advanced stem cell models, Human Technopole researchers show how mutations in the YY1 gene cause widespread dysregulation of genes crucial for brain development in multiple cell types, leading to structural abnormalities and impaired neuronal function. The results of the research are published in the Nature Portfolio journal Molecular Psychiatry.
-
2 fully funded PhD fellowships at HT through SISSA
Human Technopole is offering 2 fully funded 4-year PhD fellowships to young scientists from the national and international community who wish to undertake a doctoral degree on a project focused on Computational Biology.
-
Thyroid: Understanding the Molecular Mechanism of Thyroxine Synthesis
A study from Human Technopole, the University of Milano-Bicocca and Università di Milano reveals new details about how thyroxine – the primary form of thyroid hormone in the blood – is formed, shedding light on a mechanism involving a specific type of amino acid in the thyroglobulin protein. The findings are published in The Journal of Biochemistry and highlighted with the journal’s cover.